Author: OurCrowd

[Quantum Machines in HPC Wire] Quantum Machines and QuEra Computing secure BIRD Foundation grant for photonic control unit

Nov 7, 2023 |

TEL AVIV, Israel and BOSTON, Nov. 7, 2023 — Quantum Machines and QuEra Computing today announced they have been awarded an innovation grant from the Board of Governors of the Israel-U.S. Binational Industrial Research and Development (BIRD) Foundation to jointly develop a photonic control unit (PCU) to significantly accelerate the computational power of quantum computers today and in the future. Read more...

Read More

[BioLumic in Seed World] UV light treatment shines a bright future for row crop seeds

Nov 7, 2023 |

BioLumic recently partnered with Gro Alliance to bring Ultraviolet light-activated seed treatments to a commercial scale. The right ‘recipe’ of UV light exposure can trigger desirable results in crops such as altered nutritional profiles, pest and disease resistance, and increased yields. BioLumic’s current target is to see a 10% yield increase in crops grown from UV-treated seeds over crops from conventionally treated seeds. Listen...

Read More

[Hub Security in Globe NewsWire] Hub Security forecasts over $10 million in new contracts in 2024 from a key contract with top US enterprise AI firm in groundbreaking Big4 project

Nov 6, 2023 |

Tel Aviv, Nov. 06, 2023 (GLOBE NEWSWIRE) — via IBN — HUB Cyber Security Ltd (Nasdaq: HUBC), a developer of Confidential Computing cybersecurity solutions and services (“HUB Security” or the “Company”), today announced that it has signed a letter of intent for a financing and services agreement and strategic collaboration agreement with Blackswan Technologies, a top-tier enterprise AI company based in the United States. This strategic alliance heralds the commencement of a project in partnership with one of the Big4 Professional Services firms and their esteemed end customer, a globally renowned major banking group. The two companies are exploring the possibility of a potential merger. Read more...

Read More

[Eko Health in PR Newswire] Eko Health announces large-scale deployment of AI heart disease detection technology

Nov 6, 2023 |

EMERYVILLE, Calif. , Nov. 6, 2023 /PRNewswire/ — Eko Health, Inc. (Eko), a leader in AI technology for heart and lung disease detection, today announced the regulatory approval (UKCA marking) and frontline deployment of the company’s AI-enabled technology in the United Kingdom (UK). TRICORDER, a National Institute for Health and Care Research (NIHR) funded implementation program led by researchers at Imperial College London, will deploy Eko’s AI-enabled technology (marketed in the U.S. as SENSORA™) to primary care practices across the UK. This novel implementation will assist clinicians in their evaluation of heart failure (HF), valvular heart disease (VHD), and atrial fibrillation (AFib), ultimately serving as an AI-enabled clinical decision support tool for echocardiogram referrals. Read...

Read More